MCID: CHR070
MIFTS: 43

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Categories: Neuronal diseases

Aliases & Classifications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MalaCards integrated aliases for Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

Name: Chronic Inflammatory Demyelinating Polyradiculoneuropathy 12 14
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 69
Polyradiculoneuropathy Chronic Inflammatory Demyelinating 52

Classifications:



External Ids:

Disease Ontology 12 DOID:5213
ICD10 33 G61.81
ICD9CM 35 357.81
MeSH 42 D020277
NCIt 47 C84636
SNOMED-CT 64 128209004 444728005
UMLS 69 C0393819

Summaries for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MalaCards based summary : Chronic Inflammatory Demyelinating Polyradiculoneuropathy, also known as polyradiculoneuropathy, chronic inflammatory demyelinating, is related to chronic inflammatory demyelinating polyneuropathy and chronic inflammatory demyelinating polyneuritis. An important gene associated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy is MPZ (Myelin Protein Zero), and among its related pathways/superpathways are Allograft rejection and Immune response Role of DAP12 receptors in NK cells. The drugs Antibodies and gamma-Globulins have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, t cells and skin, and related phenotypes are cellular and homeostasis/metabolism

Related Diseases for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 124)
id Related Disease Score Top Affiliating Genes
1 chronic inflammatory demyelinating polyneuropathy 11.9
2 chronic inflammatory demyelinating polyneuritis 11.2
3 polyradiculoneuropathy 11.1
4 chromosome 16p13.2 deletion syndrome 10.7 MPZ PMP22
5 hereditary proximal myopathy with early respiratory failure 10.7 MPZ PMP22
6 conotruncal heart malformations 10.7 MPZ PMP22
7 hemiplegia alterans 10.7 MPZ PMP22
8 congestive heart failure 10.7 MPZ PMP22
9 charcot-marie-tooth neuropathy type 4j 10.7 MPZ PMP22
10 mental retardation, x-linked, syndromic 34 10.6 MPZ PMP22
11 charcot-marie-tooth disease, type 1b 10.6 MPZ PMP22
12 charcot-marie-tooth neuropathy x 10.6 MPZ PMP22
13 hypertrophic osteoarthropathy, primary, autosomal recessive 2 10.6 MPZ PMP22
14 charcot-marie-tooth disease, type 1e 10.6 MPZ PMP22
15 infantile epileptic encephalopathy 10.6 MPZ PMP22
16 renal dysplasia, cystic 10.6 MPZ PMP22
17 neuropathy, recurrent, with pressure palsies 10.6 MPZ PMP22
18 thrombophilia due to antithrombin iii deficiency 10.6 MPZ PMP22
19 hypoxia 10.5 MPZ PMP22
20 pituitary adenoma, growth hormone-secreting 10.5 MPZ PMP22
21 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids 10.5 ALB IFNG
22 primary systemic mycosis 10.5 IFNG IL17A
23 tonsil cancer 10.5 ALB IFNG
24 polyarteritis nodosa 10.5 ALB IFNG
25 childhood brain stem glioma 10.5 ALB IFNG
26 mohr-tranebjaerg syndrome 10.5 MPZ PMP22
27 hepadnavirus infection 10.4 ALB IFNG
28 hereditary choroidal atrophy 10.4 IFNG IL17A
29 lipid metabolism disorder 10.4 IFNB1 IFNG
30 cryptogenic organizing pneumonia 10.4 ALB IL17A
31 periventricular leukomalacia 10.4 IFNG IL17A
32 ethmoid sinus cancer 10.4 IFNG STAT1
33 cutaneous fibrous histiocytoma 10.4 ALB IFNG
34 neuropathy, inflammatory demyelinating 10.4 MPZ PMP22
35 hunter macpherson syndrome 10.4 IFNG STAT1
36 combined cellular and humoral immune defects with granulomas 10.3 IFNG IL17A
37 neuropathy 10.3
38 infertility 10.3 ALB PMP22
39 cellulitis 10.3 IFNB1 IL17A
40 loiasis 10.3 IFNG IL17A
41 status epilepticus 10.3 IFNG MPZ PMP22
42 spoan syndrome 10.3 IFNB1 STAT1
43 choreatic disease 10.3 ALB MPZ PMP22
44 orbital osteomyelitis 10.3 IFNG IL17A
45 esophagus squamous cell papilloma 10.2 IFNB1 STAT1
46 disease of mental health 10.2 IFNG IL17A
47 multifocal motor neuropathy 10.2
48 rift valley fever 10.2 ALB IFNG
49 ostertagiasis 10.2 IFNB1 IL17A
50 cornea cancer 10.2 IFNG IL17A

Graphical network of the top 20 diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:



Diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Symptoms & Phenotypes for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MGI Mouse Phenotypes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.02 ALB CXCR4 IFNG MPZ PMP22 PRF1
2 homeostasis/metabolism MP:0005376 9.97 ALB CXCR4 IFNB1 IFNG IL17A MPZ
3 hematopoietic system MP:0005397 9.95 CXCR4 IFNB1 IFNG IL17A MPZ PRF1
4 endocrine/exocrine gland MP:0005379 9.91 ALB CXCR4 IFNG IL17A PRF1 STAT1
5 immune system MP:0005387 9.87 STAT1 CXCR4 IFNB1 IFNG IL17A MPZ
6 mortality/aging MP:0010768 9.86 ALB CXCR4 IFNG IL17A MPZ PMP22
7 digestive/alimentary MP:0005381 9.85 ALB CXCR4 IFNG IL17A STAT1
8 muscle MP:0005369 9.55 ALB CXCR4 IFNG PMP22 STAT1
9 neoplasm MP:0002006 9.43 ALB CXCR4 IFNB1 IFNG PRF1 STAT1
10 nervous system MP:0003631 9.17 CXCR4 IFNB1 IFNG MPZ PMP22 PRF1

Drugs & Therapeutics for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Drugs for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 42)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
2 gamma-Globulins Phase 4,Phase 3,Phase 2
3 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
4 Immunoglobulins, Intravenous Phase 4,Phase 3,Phase 2
5 Rho(D) Immune Globulin Phase 4,Phase 3,Phase 2
6
Prednisone Approved, Vet_approved Phase 3 53-03-2 5865
7
Benzocaine Approved Phase 3 1994-09-7, 94-09-7 2337
8
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
9
Mycophenolic acid Approved Phase 3 24280-93-1 446541
10
Glycine Approved, Nutraceutical, Vet_approved Phase 3 56-40-6 750
11 tannic acid Approved, Nutraceutical Phase 3
12 Fingolimod Hydrochloride Phase 3
13 Immunosuppressive Agents Phase 3,Phase 2
14 Anti-Inflammatory Agents Phase 3
15 Antineoplastic Agents, Hormonal Phase 3
16 glucocorticoids Phase 3
17 Hormone Antagonists Phase 3,Phase 2
18 Hormones Phase 3,Phase 2
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
20 3,4-diaminopyridine Phase 3
21 Potassium Channel Blockers Phase 3
22 Pharmaceutical Solutions Phase 3,Phase 2
23 Anti-Bacterial Agents Phase 3
24 Antibiotics, Antitubercular Phase 3
25
Interferon beta-1a Approved, Investigational Phase 2 145258-61-3 6438354
26
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
27 Adjuvants, Immunologic Phase 2
28 Anti-Infective Agents Phase 2
29 Antiviral Agents Phase 2
30 Interferon-beta Phase 2
31 interferons Phase 2
32 Antioxidants Phase 2
33 Micronutrients Phase 2
34 Protective Agents Phase 2
35 Thioctic Acid Phase 2
36 Trace Elements Phase 2
37 Vitamin B Complex Phase 2
38 Vitamins Phase 2
39 Alpha-lipoic Acid Nutraceutical Phase 2
40 Folate Nutraceutical Phase 2
41 Vitamin B9 Nutraceutical Phase 2
42 Antibodies, Anti-Idiotypic

Interventional clinical trials:

(show all 44)

id Name Status NCT ID Phase Drugs
1 IVIg for Demyelination in Diabetes Mellitus Recruiting NCT02372149 Phase 4 10% intravenous immunoglobulin (IVIg);0.9% sodium chloride
2 MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study Active, not recruiting NCT03226119 Phase 4
3 Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) Withdrawn NCT01757574 Phase 4 Alemtuzumab infusion
4 Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. Completed NCT01625182 Phase 3 Fingolimod;Placebo Comparator
5 Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Completed NCT01824251 Phase 3 NPB-01
6 Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy Completed NCT01184846 Phase 3
7 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) Completed NCT01545076 Phase 3
8 Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed NCT02027701 Phase 3
9 Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed NCT00220740 Phase 3 Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified;Albumin (Human) 25%, United States Pharmacopeia (USP)
10 Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy Completed NCT00004772 Phase 3 Immune globulin
11 Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg Completed NCT01349270 Phase 3 Immunoglobulin perfusion;Prednisone
12 Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy Completed NCT00004286 Phase 3 immune globulin
13 Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy Completed NCT00004939 Phase 3 ,4-diaminopyridine
14 Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP Recruiting NCT02955355 Phase 3
15 Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Recruiting NCT02293460 Phase 3 I10E
16 Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 Recruiting NCT02317562 Phase 3 I10E
17 Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP Recruiting NCT02549170 Phase 3
18 Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy Recruiting NCT02638207 Phase 3 NewGam
19 Interest of Mycophenolate for CIDP Weaning Active, not recruiting NCT02494505 Phase 3 Mycophenolate Mofetil;placebo
20 Panzyga in CIDP Administered at Different Infusion Rates Not yet recruiting NCT03166527 Phase 3 Immune Globulin 10% Intravenous Solution
21 Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP Terminated NCT01225276 Phase 2, Phase 3 NewGam 10%;Placebo;NewGam 10%;NewGam 10%
22 Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Completed NCT00099489 Phase 2 Interferon Beta-1a
23 Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Completed NCT01017159 Phase 2 Subcutaneous immunoglobulin
24 Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy Completed NCT00962429 Phase 2 lipoic acid
25 Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Completed NCT00001287 Phase 2 intravenous immunoglobulin (IVIg)
26 Stem Cell Transplantation for Stiff Person Syndrome (SPS) Recruiting NCT02282514 Phase 1, Phase 2
27 SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Recruiting NCT02967679 Phase 1, Phase 2 MD1003
28 Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Active, not recruiting NCT00278629 Phase 2
29 High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy Withdrawn NCT01236456 Phase 2 Cyclophosphamide
30 Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy Withdrawn NCT02574962 Phase 2 H.P. Acthar® Gel
31 A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 Suspended NCT03275740 Phase 1 PF-06755347;Placebo comparator
32 Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Unknown status NCT01379833
33 sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN Unknown status NCT02271724
34 MRI in Diagnosing and Monitoring CIDP Completed NCT02017769
35 Study of CIDP Patients During IVIG Treatment Completed NCT00305266 intravenous gammaglobulin
36 Effect of Resistance and Aerobic Exercise in CIDP or MMN Completed NCT02121678
37 Immunoglobulin Dosage and Administration Form in CIDP and MMN Completed NCT02111590 Immunoglobulins
38 Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy Completed NCT01847937
39 Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Recruiting NCT02629796
40 Transcriptome Analysis of the Peripheral Blood in CIDP Recruiting NCT02404298 IVIg
41 Subcutaneous Immunoglobulin for CIDP Recruiting NCT02465359 Immune Globulin Subcutaneous (Human)
42 IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements Recruiting NCT02414490 Intravenous Immunoglobulin
43 Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin Not yet recruiting NCT02892890
44 Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuro Not yet recruiting NCT03008733

Search NIH Clinical Center for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Anatomical Context for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

MalaCards organs/tissues related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

39
Spinal Cord, T Cells, Skin, Brain, Tongue, Nk Cells, Thyroid

Publications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Articles related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

(show top 50) (show all 314)
id Title Authors Year
1
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. ( 28481421 )
2017
2
Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy. ( 28646568 )
2017
3
Chronic inflammatory demyelinating polyradiculoneuropathy and anesthesia: a case series. ( 28936613 )
2017
4
Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment. ( 28382108 )
2017
5
Rituximab in refractory chronic inflammatory demyelinating polyradiculoneuropathy: report of four cases. ( 28337614 )
2017
6
Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy. ( 28215575 )
2017
7
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. ( 28084646 )
2017
8
Multiple Sites Ultrasonography of Peripheral Nerves in Differentiating Charcot-Marie-Tooth Type 1A from Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 28522988 )
2017
9
Chronic inflammatory demyelinating polyradiculoneuropathy-causing myelopathy. ( 28786217 )
2017
10
Multiple Myeloma Associated Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Importance of Continued Surveillance. ( 28070468 )
2016
11
A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA. ( 27580763 )
2016
12
Fatigue, Pain, Anxiety and Depression in Guillain-BarrAc Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 27077919 )
2016
13
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy. ( 27230584 )
2016
14
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)? ( 26750580 )
2016
15
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies. ( 27902997 )
2016
16
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid Use. ( 27438336 )
2016
17
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 26977594 )
2016
18
Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg Response. ( 27175635 )
2016
19
Chronic inflammatory demyelinating polyradiculoneuropathy occurring after autologous haematopoietic stem cell transplantation for multiple sclerosis. ( 28607734 )
2016
20
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. ( 27781132 )
2016
21
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-BarrAc syndrome: a case report. ( 27380808 )
2016
22
A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon I+-2a in a patient with chronic hepatitis B virus infection. ( 27680223 )
2016
23
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. ( 27286956 )
2016
24
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. ( 26873805 )
2016
25
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 27211560 )
2016
26
Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand. ( 27113227 )
2016
27
Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data. ( 27313890 )
2016
28
Chronic inflammatory demyelinating polyradiculoneuropathy: A new animal model for new therapeutic targets. ( 27838091 )
2016
29
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. ( 27241239 )
2016
30
A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia. ( 27580761 )
2016
31
IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. ( 27852440 )
2016
32
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog. ( 26450833 )
2015
33
Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. ( 25571892 )
2015
34
Maintenace therapy in chronic inflammatory demyelinating polyradiculoneuropathy. ( 26088325 )
2015
35
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. ( 26305459 )
2015
36
Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. ( 25556954 )
2015
37
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. ( 25561247 )
2015
38
Which criteria for research in chronic inflammatory demyelinating polyradiculoneuropathy? an analysis of current practice. ( 25354388 )
2015
39
Characteristic MRI features of chronic inflammatory demyelinating polyradiculoneuropathy. ( 25687202 )
2015
40
The diagnostic value of MRI in pediatric chronic inflammatory demyelinating polyradiculoneuropathy. ( 25972306 )
2015
41
The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis. ( 26198918 )
2015
42
Update on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. ( 26203970 )
2015
43
Chronic inflammatory demyelinating polyradiculoneuropathy with cranial nerves hypertrophy, thyroid-related orbitopathy and IgG monoclonal gammopathy: a case report. ( 25647292 )
2015
44
New insights into the management of chronic inflammatory demyelinating polyradiculoneuropathy. ( 26107324 )
2015
45
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies. ( 26392214 )
2015
46
Relapse with Dysphagia in a Case of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( 26179538 )
2015
47
Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. ( 25677463 )
2015
48
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice. ( 26437234 )
2015
49
Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. ( 24887608 )
2014
50
Progressive bilateral ptosis in a patient with midbrain metastasis and chronic inflammatory demyelinating polyradiculoneuropathy. ( 24594646 )
2014

Variations for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Expression for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Search GEO for disease gene expression data for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Pathways for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Pathways related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 18)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.4 CXCR4 IFNG IL17A PRF1 STAT1
2
Show member pathways
12.23 IFNB1 IFNG PRF1
3 12.12 CXCR4 IFNG IL17A STAT1
4
Show member pathways
12.03 IFNB1 IFNG STAT1
5 11.92 IFNB1 IFNG STAT1
6
Show member pathways
11.89 IFNB1 IFNG STAT1
7
Show member pathways
11.85 IFNB1 IFNG STAT1
8 11.72 IFNB1 IFNG STAT1
9
Show member pathways
11.61 IFNG IL17A STAT1
10
Show member pathways
11.58 IFNG STAT1
11
Show member pathways
11.55 IFNG IL17A STAT1
12 11.2 CXCR4 IFNB1 IFNG STAT1
13
Show member pathways
11.13 IFNB1 IFNG IL17A STAT1
14 11.06 IFNG IL17A
15 11.02 IFNB1 IFNG
16 10.97 IFNG PRF1
17
Show member pathways
10.97 IFNG PRF1
18 10.9 IFNB1 IFNG STAT1

GO Terms for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Biological processes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 apoptotic process GO:0006915 9.65 CXCR4 IFNG IL17A PRF1 STAT1
2 myelination GO:0042552 9.51 MPZ PMP22
3 response to virus GO:0009615 9.5 CXCR4 IFNB1 IFNG
4 cell death GO:0008219 9.49 IL17A PMP22
5 regulation of type I interferon-mediated signaling pathway GO:0060338 9.48 IFNB1 STAT1
6 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.46 IFNB1 IFNG
7 positive regulation of osteoclast differentiation GO:0045672 9.43 IFNG IL17A
8 cellular response to interferon-beta GO:0035458 9.4 IFNB1 STAT1
9 regulation of interferon-gamma-mediated signaling pathway GO:0060334 9.37 IFNG STAT1
10 positive regulation of interleukin-23 production GO:0032747 9.16 IFNG IL17A
11 positive regulation of killing of cells of other organism GO:0051712 8.96 IFNG PRF1
12 defense response to virus GO:0051607 8.92 IFNB1 IFNG PRF1 STAT1

Molecular functions related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.8 IFNB1 IFNG IL17A

Sources for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....